(Q37774910)

23 August 2017

1 reference

title

Evidence-based recommendations for the treatment of aggression in pediatric patients with attention deficit hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

23 August 2017

1 reference

1 reference

Betsy A List

1

1 reference

PubMed ID

20652408

23 August 2017

Drew H Barzman

series ordinal

2

1 reference

PubMed ID

20652408

23 August 2017

language of work or name

1 reference

1 March 2011

1 reference

23 August 2017

Psychiatric Quarterly

1 reference

23 August 2017

82

1 reference

23 August 2017

1

1 reference

23 August 2017

33-42

1 reference

https://scigraph.springernature.com/pub.10.1007/s11126-010-9145-z

23 August 2017

0 references

cites work

AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry.

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Let Evidence Guide Every New Decision (LEGEND): an evidence evaluation system for point-of-care clinicians and guideline development teams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Psychosocial interventions for disruptive and aggressive behaviour in children and adolescents: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Pharmacological treatment of pathologic aggression in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-010-9145-Z

Psychopharmacologic strategies for the treatment of aggression in juveniles.

21 January 2018

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.

1 reference

12 December 2020

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

1 reference

12 December 2020

Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

12 December 2020

Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents

1 reference

12 December 2020

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

1 reference

12 December 2020

Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.

1 reference

12 December 2020

Pharmacotherapy of aggression in children and adolescents: efficacy and effect size

1 reference

12 December 2020

10.1007/S11126-010-9145-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20652408